IceCure Highlights Clinical Data and Strong Physician Engagement for ProSense® Breast Cancer Cryoablation at EUSOBI 2026

ConferenceProSense®Positive

AI Analysis

Summary

IceCure Medical presented clinical data and research on ProSense® breast cancer cryoablation at EUSOBI 2026, featuring scientific presentations, posters, and clinical workshops demonstrating strong physician engagement across Europe.

Importance:4/10

Sentiment:

0.60

clinical dataconference presentationphysician engagementbreast cancercryoablationEUSOBI 2026

Related Companies

$ICCM

Read the original article

Published by PR Newswire Pharma on October 13, 2026 12:05 PM

Read Original